Prostate cancer management-Reference-Cited by-同舟云学术

Prostate cancer management

Published:2004-10 Issue: Volume:15 Page:iv307-iv312
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Horwich A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/suppl_4/iv307/453671/mdh944.pdf

Reference38 articles.

1. High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: an autopsy study of 249 cases;Sakr;In Vivo,1994

2. The influence of finasteride on the development of prostate cancer;Thompson;N Engl J Med,2003

3. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer;Albertsen;JAMA,1998

4. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer;Harisinghani;N Engl J Med,2003

5. Prostate-specific antigen after anatomic radical retropubic prostatectomy;Pound;Patterns of recurrence and cancer control. Urol Clin North Am,1997

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers;Nature Reviews Urology;2013-02-26

2. Coagulation of human prostate volumes with MRI-controlled transurethral ultrasound therapy: Results in gel phantoms;Medical Physics;2012-07-03

3. Investigation of power and frequency for 3D conformal MRI-controlled transurethral ultrasound therapy with a dual frequency multi-element transducer;International Journal of Hyperthermia;2012-01-11

4. Low-dose rate brachytherapy for men with localized prostate cancer;Cochrane Database of Systematic Reviews;2011-07-06

5. Urinary N-telopeptide (uNTx) is an independent prognostic factor for overall survival in patients with bone metastases from castration-resistant prostate cancer;Annals of Oncology;2010-09